STOCKHOLM, Dec 6, 2008 (AFP) - Luc Montagnier, co-winner of the 2008 Nobel Prize for Medicine, Saturday stood by his view that a "therapeutic vaccine" for the AIDS pandemic could be created within four to five years.
"It is difficult to say, but it is perhaps a case of four to five years," he told AFP, following a press conference in Stockholm ahead of receiving the prestigious prize next week.
In October Montagnier, 76, said an AIDS treatment could be possible in the future with a "therapeutic" rather than preventive vaccine for which results might be published in three or four years if financial backing is forthcoming.
Montagnier and fellow French researcher Francoise Barre-Sinoussi, who shared the Nobel prize, discovered the human immunodeficiency virus (HIV) that causes AIDS by destroying immune cells, one of the scourges of modern times.
On Saturday Montagnier insisted the creation of a "therapeutic vaccine" within four to five years was realistic and that there are various ways to reduce the HIV virus until a cure is found.
He noted that work on a vaccine has been going on for 10 years and that it was easier to research a therapeutic rather than a preventative vaccine.
"Before we get a vaccine there are many ways to reduce the contaminations by improving ways of life standards in developing and poor countries, in giving them more advice," he said.
While also addressing journalists in Stockholm, Barre-Sinoussi said it is impossible to say when a preventitive AIDS vaccine would be made available and that researchers must keep working on it.
Montagnier and Barre-Sinoussi shared one half of the 2008 award, while the other half went to Harald zur Hausen of Germany, who discovered the virus that causes cervical cancer.
Zur Hausen also attended Saturday's press conference in which he echoed Barre-Sinoussi's response that winning the Nobel prize had completely changed his life.
All three researchers will give their acceptance speech on Sunday and receive their award, with a cheque for 10 million Swedish kronor (930,000 euros), on Wednesday.
AIDS (acquired immune deficiency syndrome) has claimed more than 25 million lives since it first came to prominence in 1981. Today, around 33 million people are living with AIDS or harbouring HIV, 67 percent of them south of the Sahara.
081206
AF081220
Copyright ©AFP 2008. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP photos or materials. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP stories, photos or graphics. http://www.afp.com/
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.